HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valeria Bozzi Selected Research

Hematopoietic Stem Cell Transplantation

1/2018Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valeria Bozzi Research Topics

Disease

10Thrombocytopenia (Thrombopenia)
01/2022 - 07/2009
10MYH9-Related Disorders
02/2019 - 03/2008
4Hemorrhage
01/2022 - 03/2011
1Scleroatonic muscular dystrophy
01/2023
1Lymphoma (Lymphomas)
01/2023
1Starvation
01/2023
1B-Cell Leukemia (Leukemia, B Cell)
01/2023
1Inborn Genetic Diseases (Disease, Hereditary)
01/2023
1Deafness (Deaf Mutism)
02/2019
1Cataract (Cataracts)
02/2019
1Congenital amegakaryocytic thrombocytopenia
01/2018
1Bone Marrow Failure Disorders
01/2018
1Infections
01/2018
1Neoplasms (Cancer)
01/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017
1Thrombocytopenia chromosome breakage
01/2017
1Crohn Disease (Crohn's Disease)
07/2015
1Bernard-Soulier Syndrome (Giant Platelet Syndrome)
03/2011
1Disease Progression
05/2007
1Granuloma
03/2007
1Sarcoidosis (Schaumann Disease)
03/2007
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
11/2006
1Autoimmune Lymphoproliferative Syndrome
11/2006

Drug/Important Bio-Agent (IBA)

6Nonmuscle Myosin Type IIAIBA
10/2011 - 03/2008
4Myosin Heavy Chains (Myosin Heavy Chain)IBA
02/2019 - 03/2008
3EnzymesIBA
01/2022 - 01/2012
2CollagenIBA
01/2023 - 01/2019
2eltrombopagFDA Link
01/2019 - 12/2010
2Thrombopoietin (c-mpl Ligand)IBA
01/2018 - 12/2010
25' Untranslated Regions (5' UTR)IBA
01/2017 - 01/2011
2Collagen Type I (Type I Collagen)IBA
10/2011 - 07/2009
2LigandsIBA
05/2007 - 03/2007
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2023
17-aminoactinomycin DIBA
01/2023
1enhanced green fluorescent proteinIBA
01/2023
1X-Box Binding Protein 1IBA
01/2023
1Endoplasmic Reticulum Chaperone BiPIBA
01/2023
1CalciumIBA
01/2023
1Cysteine (L-Cysteine)FDA Link
01/2023
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2023
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2023
1Peptides (Polypeptides)IBA
01/2023
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2023
1Phosphotransferases (Kinase)IBA
01/2023
1Protease Inhibitors (Protease Inhibitor)IBA
01/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1Serine (L-Serine)FDA Link
01/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023
1Sirolimus (Rapamycin)FDA Link
01/2023
1Collagen Type VIIBA
01/2023
1Small Interfering RNA (siRNA)IBA
01/2023
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
01/2023
1Lysosomal-Associated Membrane Protein 2IBA
01/2023
1Protein Phosphatase 1IBA
01/2023
1glucose-regulated proteinsIBA
01/2023
1Transcription Factors (Transcription Factor)IBA
01/2022
1Adenosine Diphosphate (ADP)IBA
01/2022
1convulxinIBA
01/2019
1romiplostimFDA Link
01/2018
14,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA
01/2018
1NucleotidesIBA
01/2017
1Fibrinogen (Factor I)FDA Link
11/2016
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
07/2015
1AntigensIBA
07/2015
1von Willebrand FactorIBA
03/2011
1Thrombopoietin ReceptorsIBA
12/2010
1Complementary DNA (cDNA)IBA
12/2008
1Receptor for Advanced Glycation End ProductsIBA
03/2007
1S100A12 ProteinIBA
03/2007
1Death Domain ReceptorsIBA
11/2006
1PerforinIBA
11/2006

Therapy/Procedure

1Artificial Respiration (Mechanical Ventilation)
01/2023
1Therapeutics
01/2018
1Hematopoietic Stem Cell Transplantation
01/2018
1Platelet Transfusion (Blood Platelet Transfusions)
12/2010
1Transjugular Intrahepatic Portasystemic Shunt
07/2009